On Wednesday we welcomed over 50+ investors to our Health Tech showcase at the Bloomsbury Hotel, spotlighting the fantastic work being done across our portfolio of #healthtech companies, all focused on developing a range of potentially life-changing technologies: 🧠Amber Therapeutics - Neuromodulation therapy to treat mixed urinary incontinence 🫀Caristo Diagnostics - Coronary Inflammation detection 🩺Genomics plc - Genomic prevention to detect and eliminate the genetic risk of common diseases 🫀Ultromics - AI-powered heart failure detection 🔬Refeyn - Molecular mass photometry to aid in bioanalytic scientific discovery, R&D and therapeutics production 📱Neu Health- Smartphone App & clinician dashboard, making the latest Parkinson’s disease and dementia care accessible for all Thank you so much to our CEOs who presented: Tim Denison, Ph.D., Aidan Crawley, Frank Cheng, Peter Donnelly, Ross Upton, PhD, Gerry Mackay and Caroline Cake We’re excited to continue working with our partners and co-investors to help grow these companies into leaders in their space. 🚀
Great to see the Ultromics solution for HFpEF diagnosis showcased at this event. Thanks to OSE.
Fantastic innovation on display Stuart Calvert People Puzzles
Always delighted to see Oxford Science Enterprises striving and the University of Oxford 's ecosystem to lead.